Loading…
Improving Access to Home Dialysis Act of 2021
Legislative Progress
Introduced
September 29, 2021
Latest Action
September 30, 2021
Primary Sponsor
Bobby L. RushDemocratic(IL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Improving Access to Home Dialysis Act of 2021 This bill provides for Medicare coverage of staff-assisted home dialysis services for certain individuals with end-stage renal disease (ESRD). Specifically, the bill provides for coverage of services for ESRD individuals who are either initiating peritoneal or home hemodialysis or receiving home dialysis and are unable to self-dialyze due to illness, injury, caregiver issues, or other temporary circumstances. The Centers for Medicare & Medicaid Services must develop a payment system for such services. The bill also requires the development of a patient-centered decision tool that includes home dialysis as an option, as well as a report on racial disparities with respect to the use of staff-assisted home dialysis services.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2022 · fourth_quarter · Health Issues
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Issues related to End Stage Renal Disease Perspective Payment System HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act H.R. 8063, Repair Abuses of MSP Payments Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $960,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease Perspective Payment System HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act H.R. 8063, Repair Abuses of MSP Payments Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $960,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. H.R. 8594 and S. 4750, "Restore Protections for Dialysis Patients Act," to provide Medicare access to kidney dialysis. Letter to HHS regarding Final Rule for the Medicare Part B-ID benefit to extend eligibility of coverage of immunosuppressive drugs for kidney transplant recipients for Medicare ESRD beneficiaries. Support for Protected Classes under Medicare Part D program. S. 4873, Improving Access to Advance Care Planning Act for Medicare advanced care planning. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. Support for Kidney Health Evaluation (KED) for patients with diabetes. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Participated in health community effort to urge HHS to expand Medicare coverage to include medically necessary dental treatments for solid organ transplant recipients and other vulnerable individuals.
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Health Issues
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · third_quarter · Medicare/Medicaid
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Submitted comments on Proposed Rules for the ESRD Prospective Payment System, ESRD Quality Incentive Program, and ESRD Treatment Choices Model. Submitted comments on Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System. Submitted comments on Proposed 2023 Payment Policies under the Physician Fee Schedule. Responded to RFI on Medicare Advantage. H.R. 8594 and S. 4750, "Restore Protections for Dialysis Patients Act," to provide Medicare access to kidney dialysis. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. Support for Kidney Health Evaluation (KED) for patients with diabetes. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Participated in health community effort to urge HHS to expand Medicare coverage to include medically necessary dental treatments for solid organ transplant recipients and other vulnerable individuals.
2022 · third_quarter · Health Issues
Issues related to End Stage Renal Disease Perspective Payment System HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act H.R. 8063, Repair Abuses of MSP Payments Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
2022 · third_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease Perspective Payment System HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act H.R. 8063, Repair Abuses of MSP Payments Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
2022 · third_quarter · Health Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
2022 · second_quarter · Health Issues
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
Issues related to End Stage Renal Disease Perspective Payment System (no legislation introduced) HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 Issues related to the Medicare Secondary Payor (MSP) Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
2022 · second_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease Perspective Payment System (no legislation introduced) HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 Issues related to the Medicare Secondary Payor (MSP) Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
2022 · second_quarter · Health Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
2022 · first_quarter · Health Issues
Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 Issues related to the Medicare Secondary Payor (MSP) Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $1,280,000 · Firm income: Not reported
2022 · first_quarter · Medicare/Medicaid
Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 Issues related to the Medicare Secondary Payor (MSP) Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $1,280,000 · Firm income: Not reported
2022 · first_quarter · Health Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Client expense: Not reported · Firm income: $30,000
2022 · first_quarter · Health Issues
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Health Issues
H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding Cures 2.0, draft legislation
Client expense: $860,000 · Firm income: Not reported
2021 · third_quarter · Medicare/Medicaid
H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding Cures 2.0, draft legislation
Client expense: $860,000 · Firm income: Not reported
2021 · fourth_quarter · Medicare/Medicaid
Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 Issues related to the Medicare Secondary Payor (MSP) Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $920,000 · Firm income: Not reported
2021 · fourth_quarter · Health Issues
Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 Issues related to the Medicare Secondary Payor (MSP) Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $920,000 · Firm income: Not reported
2021 · fourth_quarter · Medicare/Medicaid
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Request to expedite the rulemaking process following the 116th Congress enactment of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534, S. 3353) to provide Medicare Part B coverage of anti-rejection medications for kidney transplant recipients who lack private, group or other public health insurance coverage for these medications.
2021 · fourth_quarter · Health Issues
Home dialysis/home therapies issues; H.R. 5426 - Improving Access to Dialysis Act; H.R. 4065 and S. 1971 - Chronic Kidney Disease Improvement Act; H.R. 2903 and S. 1512 - CONNECT Act; H.R. 1255 and S. 377 - Living Donor Protection Act; H.R. 2568 and S. 1220 - US Cadet Nurse Corps Service Recognition Act.
Client expense: Not reported · Firm income: $30,000
2021 · third_quarter · Health Issues
H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding Cures 2.0, draft legislation
Client expense: $850,000 · Firm income: Not reported
2021 · third_quarter · Medicare/Medicaid
H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program Fiscal Year 2022 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding Cures 2.0, draft legislation
Client expense: $850,000 · Firm income: Not reported
2021 · third_quarter · Medicare/Medicaid
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
| Republican |
| PA |
| Danny K. Davis | Democratic | IL |
| Deborah K. Ross | Democratic | NC |
| Donald M. Payne, Jr. | Democratic | NJ |
| Earl Blumenauer | Democratic | OR |
| Eleanor Holmes Norton | Democratic | DC |
| Jason Smith | Republican | MO |
| John H. Rutherford | Republican | FL |
| Mark DeSaulnier | Democratic | CA |
| Mark Pocan | Democratic | WI |
| Markwayne Mullin | Republican | OK |
| Melanie A. Stansbury | Democratic | NM |
| Michael F. Doyle | Democratic | PA |
| Steve Cohen | Democratic | TN |
| Ted Lieu | Democratic | CA |
| Troy A. Carter | Democratic | LA |
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $950,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $950,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $850,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $850,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)